Akebia Therapeutics, Inc. 10-Q filing
Filed 2025-11-10 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001517022-25-000046
- Form type
- 10-Q
- CIK
- 0001517022
- Primary document
- https://www.sec.gov/Archives/edgar/data/1517022/000151702225000046/akba-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Akebia Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $178.6M | - | - |
| Cost Of Revenue | $26.9M | - | - |
| Operating Income | $32.1M | - | - |
| Net Income | $6.9M | - | - |
| Eps Basic | 0.03 | - | - |
| Eps Diluted | 0.03 | - | - |
| Cash And Equivalents | $166.4M | - | - |
| Total Assets | $364.2M | - | - |
| Total Liabilities | $322.6M | - | - |
| Shareholders Equity | $41.6M | - | - |
| Operating Cash Flow | $36.9M | - | - |
| Capital Expenditures | $221,000 | - | - |